Announcements

Call for Abstracts: Georgia CTSA 2019 ConferenceAbstract submission deadline: Monday, 12/3 This conference takes place Thursday 2/28/2019- Friday, 3/1/2019 at Callaway Resort and Gardens in Pine Mountain GA. The goal of the Georgia Clinical & Translational Science Conference is to bring together researchers from across the state to present the best new clinical and translational research and build collaborative relationships. Abstract submission form | Read more

Need help navigating the Department of Medicine Research Administration Service (RAS) Unit? The DOM RAS Unit has issued a one-page document to assist you in working your way through the grant submission process starting with pre-award.Read more (PDF)

Reminder: Georgia CTSA KL2 Program Clinical & Translational research career development program for junior faculty members Deadline: Friday, 3/1/2019 The goal of the program is to support and enhance career development for junior faculty (MD, PhD, MD/PhD, or PharmD) committed to a career in clinical and/or translational research. The Georgia CTSA program is committed to assisting junior faculty at partner institutions to become independent, established, and ethical clinical and/or translational research investigators. Register for the free two-session KL2 Application Workshops on December 4 and 11. Read more

Highlighted Resource

Data Analytics and Statistics Core The Data Analytics and Biostatistics (DAB) Core seeks to provide high-quality biostatistics and IT Data management services to the Department of Medicine by leveraging existing services in the Rollins School of Public Health and the Information Technology Department. Read more

Funding & Award Opportunities

Novel approaches for relating genetic variation to function and disease (R34/R44 clinical trial not allowed)Deadline: Tuesday, 12/4 (LOI) This program announcement aims to support the development of novel and generalizable commercial approaches to study how genetic variants lead to differences in function and to study how such functional differences affect human health and disease processes or how this knowledge can be used clinically. Read more

No (type) one left behind: Expanding artificial pancreas adoption and access among targeted populations Deadline: Wednesday, 12/5 JDRF is committed to expanding the reach of artificial pancreas (AP) systems and the benefits they can provide to people with type 1 diabetes (T1D) – of all ages and stages. Read more

Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS, Second wave) (UG3/UH3 clinical trial required) Deadline: Tuesday, 12/11 (LOI) The purpose of this FOA is to promote research in colorectal cancer (CRC) screening, follow-up, and referral-to-care in regions of the United States (U.S.) where screening rates are below national standards. Read more

Polycystic Kidney Disease (PKD) Foundation Research Grant Deadline: Monday, 1/7/2019 The PKD Foundations principal mission is to support basic, translational and clinical research that will benefit patients with ARPKD and ADPKD. The Foundation accomplishes this in part through funding of basic and translational research. Read more

Alliance for Academic Internal Medicine (AAIM) Innovation GrantsDeadline: Friday, 1/18/2019 Do you have an inventive or novel approach that addresses an existing or emerging problem that impacts multiple AAIM associations? If so, please submit a Letter of Intent (LoI) that would summarize your original concept. The Innovation Grants Program awards $2,500 to a single institution and $5,000 to multiple institutions for these innovative ideas. Read more

Human Islet Research Network- Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 clinical trial not allowed) Deadline: Friday, 1/25/2019 This Funding Opportunity Announcement (FOA) solicits applications for the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase or protect functional human beta cell mass in patients with Type-1 Diabetes (T1D) through the controlled manipulation of beta cell replication, islet cell plasticity, and the reprogramming of pancreatic non-beta cells into beta-like cells, or through shielding the residual beta cell mass from the autoimmune environment. CTAR is part of the Human Islet Research Network (HIRN). Read more

The
Entelligence Young Investigator Program Deadline: Friday, 2/1/2019 The ENTELLIGENCE Young Investigator Program is a US-based research program consistent with Actelion Pharmaceutical US, Inc.’s commitment to basic science, translational, and clinical research in the area of pulmonary vascular disease. Read more

Research project grant (Parent R01 clinical trial required) Deadline: Standard Dates Apply This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Read more

What is your professional background?
I obtained my MD in 2008 from Moscow State University. During my time in medical school, I truly enjoyed unraveling the intricacies of disease pathogenesis and how medication, lifestyle modifications, and other interventions could mediate these processes. My love for research and my long-standing fascination with cardiac physiology spurred me to pursue a post-doctoral fellowship in cardiovascular research at Harvard Medical School, where my studies focused on the molecular mechanisms triggering the development of ventricular arrhythmias as well as the functional genomics of atrial fibrillation. After fruitful years in basic science, I continued my clinical training in Internal Medicine at Rutgers University, where my scientific efforts focused mainly on population-based outcome studies. Upon completion of my residency training, I joined Emory University as a cardiology fellow.

In what division do you work, and who is your mentor?
I am excited to join the Dr. Kathy Griendling’s laboratory in the Division of Cardiology for the research years of my fellowship and to broaden my perspective of cardiovascular biology.

Briefly describe your research. Why is it important?
Sepsis constitutes a major cause of morbidity and mortality worldwide by causing life-threatening organ dysfunction, with the heart as one of the most frequently affected organs. My current project focuses on the role of Poldip2 in sepsis-induced cardiomyopathy aiming to discern the molecular mechanisms underlying its role and to identify novel therapeutic targets to treat this life-threatening condition.

What do you like most about Emory?
From the first day, Emory really impressed me by its warm and collaborative atmosphere.

What is your favorite movie or TV show?
As for most of us, I believe, it varies at different times, but the two latest ones that I enjoyed were the documentary series World War II: Countdown to Victory and The Unknown War.

What do you like to do in your spare time?
I enjoy hiking, mountain skiing, singing songs with the guitar (mostly in Russian), writing poems (mostly in English) and, of course, spending time with my family, watching our daughter grow up. It is indeed a very special experience to participate in those activities that one gets to revisit and enjoy (once again, but in a different capacity) when one has kids.

The Emory University Department of Medicine is a component of the Robert W. Woodruff Health Sciences Center of Emory University, which includes the Emory schools of Medicine, Nursing, and Public Health; Yerkes National Primate Research Center; Winship Cancer Institute; and Emory Healthcare.